Vice President & Medical Director
Pfizer Canada Inc.
After completing his postgraduate research training at the Neurobiological Psychiatry Unit at Department of Psychiatry, McGill University, Vratislav Hadrava initiated his career in pharmaceutical industry at Pfizer Canada and has held positions of increasing responsibilities in areas of Medical Affairs, Clinical Research, Safety and Regulatory Affairs.
Vratislav Hadrava collaborated in numerous projects with clinical researchers from academia and Pfizer, mainly in the area of mental health disorders. He has acquired broad experience in clinical development and commercialization of new medicines and has developed a particular interest in the regulatory and pharmacovigilance aspects of the pharmaceutical medicine.
He has participated in several initiatives such as Health Canada/CIHR sponsored National Placebo Working Committee, Expert Advisory Committee on the Vigilance of Health Products, Drug Safety and Effectiveness Network Advisory Committee. He is co-chairing this year the Canadian annual meeting of Drug Information Association (DIA, 27-29 October, 2014).